NCT02685969 - Brain Characterization of Amyloid Protein and Glucose Metabolism of ALFA Project Participants | Biotech Hunter

Enrollment

570

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Alzheimer's Disease

Interventions

PROCEDURE

18F-Flutemetamol & 18F-FDG

Characterization of cerebral amyloid deposition with 18F-Flutemetamol PET and glucose metabolism 18F-FDG PET.

Trial Locations (1)

RECRUITING

BarcelonaBeta Brain Research Center, Barcelona

All Listed Sponsors

collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

General Electric

INDUSTRY

lead

Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

OTHER